Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Stilund M, Gjelstrup M C, Petersen T, Møller H J, Rasmussen P V, Christensen T